These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 12845616)

  • 41. Trachea rupture in tenascin-X-deficient type Ehlers-Danlos syndrome.
    Besselink-Lobanova A; Maandag NJ; Voermans NC; van der Heijden HF; van der Hoeven JG; Heunks LM
    Anesthesiology; 2010 Sep; 113(3):746-9. PubMed ID: 20693885
    [No Abstract]   [Full Text] [Related]  

  • 42. Signaling of de-adhesion in cellular regulation and motility.
    Greenwood JA; Murphy-Ullrich JE
    Microsc Res Tech; 1998 Dec; 43(5):420-32. PubMed ID: 9858339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tenascins in stem cell niches.
    Chiquet-Ehrismann R; Orend G; Chiquet M; Tucker RP; Midwood KS
    Matrix Biol; 2014 Jul; 37():112-23. PubMed ID: 24472737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of fibroblast migration by tenascin-C.
    Trebaul A; Chan EK; Midwood KS
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):695-7. PubMed ID: 17635125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions between Candida albicans and the human extracellular matrix component tenascin-C.
    López-Ribot JL; Bikandi J; San Millán RS; Chaffin WL
    Mol Cell Biol Res Commun; 1999 Jul; 2(1):58-63. PubMed ID: 10527893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways.
    Midwood KS; Schwarzbauer JE
    Mol Biol Cell; 2002 Oct; 13(10):3601-13. PubMed ID: 12388760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tenascin-X: beyond the architectural function.
    Valcourt U; Alcaraz LB; Exposito JY; Lethias C; Bartholin L
    Cell Adh Migr; 2015; 9(1-2):154-65. PubMed ID: 25793578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of tenascin and fibronectin in the rabbit cornea after excimer laser surgery.
    van Setten GB; Koch JW; Tervo K; Lang GK; Tervo T; Naumann GO; Kolkmeier J; Virtanen I; Tarkkanen A
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(2):178-83. PubMed ID: 1374356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tenascin C in metastasis: A view from the invasive front.
    Lowy CM; Oskarsson T
    Cell Adh Migr; 2015; 9(1-2):112-24. PubMed ID: 25738825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tenascin: growth and adhesion modulation--extracellular matrix degrading function: an in vitro study.
    Shrestha P; Sumitomo S; Lee CH; Nagahara K; Kamegai A; Yamanaka T; Takeuchi H; Kusakabe M; Mori M
    Eur J Cancer B Oral Oncol; 1996 Mar; 32B(2):106-13. PubMed ID: 8736172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biallelic mutations in Tenascin-X cause classical-like Ehlers-Danlos syndrome with slowly progressive muscular weakness.
    Brisset M; Metay C; Carlier RY; Badosa C; Marques C; Schalkwijk J; vanVlijmen-Willems I; Jimenez-Mallebrera C; Keren B; Jobic V; Laforêt P; Malfatti E
    Neuromuscul Disord; 2020 Oct; 30(10):833-838. PubMed ID: 32988710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression.
    Huang JY; Cheng YJ; Lin YP; Lin HC; Su CC; Juliano R; Yang BC
    J Immunol; 2010 Aug; 185(3):1450-9. PubMed ID: 20622113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Anti-adhesion molecule tenascin of the cell].
    Sakakura T; Kusakabe M
    Seikagaku; 2000 May; 72(5):365-72. PubMed ID: 10879110
    [No Abstract]   [Full Text] [Related]  

  • 54. Human epidermal keratinocytes are a source of tenascin-C during wound healing.
    Latijnhouwers M; Bergers M; Ponec M; Dijkman H; Andriessen M; Schalkwijk J
    J Invest Dermatol; 1997 May; 108(5):776-83. PubMed ID: 9129232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells.
    Yoshida T; Yoshimura E; Numata H; Sakakura Y; Sakakura T
    Virchows Arch; 1999 Nov; 435(5):496-500. PubMed ID: 10592053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased expression of tenascin-x in thoracic and abdominal aortic aneurysm tissues.
    Satoh K; Tsukamoto M; Shindoh M; Totsuka Y; Oda T; Matsumoto K
    Biol Pharm Bull; 2010; 33(11):1898-902. PubMed ID: 21048318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rescue of migratory defects of Ehlers-Danlos syndrome fibroblasts in vitro by type V collagen but not insulin-like binding protein-1.
    Viglio S; Zoppi N; Sangalli A; Gallanti A; Barlati S; Mottes M; Colombi M; Valli M
    J Invest Dermatol; 2008 Aug; 128(8):1915-9. PubMed ID: 18305566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tenascins and inflammation in disorders of the nervous system.
    Jakovcevski I; Miljkovic D; Schachner M; Andjus PR
    Amino Acids; 2013 Apr; 44(4):1115-27. PubMed ID: 23269478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in tenascin-C biology.
    Midwood KS; Hussenet T; Langlois B; Orend G
    Cell Mol Life Sci; 2011 Oct; 68(19):3175-99. PubMed ID: 21818551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tenascin-C induced signaling in cancer.
    Orend G; Chiquet-Ehrismann R
    Cancer Lett; 2006 Dec; 244(2):143-63. PubMed ID: 16632194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.